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Abstract: 
Objective: To determine the burden of diabetes mellitus (type I and II) and incidence of nephropathy in diabetic 
patients Peshawar. 
Methodology: A cross-sectional study carried out on known diabetic patients in Peshawar. This study was conducted 
on 267 diabetic patients in duration of one year (from January 2018 to February 2019). Both diabetes mellitus type I 
and type II patients was included in study. Informed consent was taken from all patients before sample collection. 
Collected samples were further processed in pathology department. Collected data was analyzed by statistical 
package for social sciences software version 21. 
Results: Out of total 267 diabetic patients, diabetes mellitus type I was observed in 43 (16.1%) patients while diabetes 
mellitus type II was examined in 224 (83.9%) patients. The incidence of nephropathy was found in 33 (12.4%) patients 
with highest percentage in female (57.5%). 
Conclusion: Diabetes mellitus type II was three times more common than diabetes mellitus type I. Nephropathy 
incidence is manageable but high risk to female diabetic patients. 
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INTRODUCTION: 
Diabetes mellitus (DM) is a worldwide growing 
epidemic and characterized by high level of glucose in 
circulation due to abnormal insulin secretion or poor 
response of tissue to insulin (Soriguer et al., 2012). 
International Diabetes Federation reported in 2014 
that about 8.2% of adults (age=20-79 year) were 
diabetic patients (da Rocha Fernandes et al., 2016). 
Mainly DM has two types e.g. Diabetes mellitus type 
1 and type 2. In Type 1 diabetes mellitus, there is no 
production of insulin whereas in Type 2 diabetes 
mellitus there is insufficient insulin or cells do not 
respond to insulin present in the body (insulin 
resistance).Type 2 DM is about 80% whereas Type 1 
diabetes accounts for 10% of cases and specific 
diabetes such as gestational diabetes accounts for 5% 
(Chako et al., 2014). Type-1 or insulin dependent 
diabetes mellitus (IDDM) mainly emerge in early 
adult life (Rehman et al., 2005). Diabetes is increasing 
continuously due to various factors such as population 
growth, aging, urbanization and increasing prevalence 
of obesity and physical inactivity(Wild et al., 2004). 
 
Diabetic nephropathy is described by proteinuria, 
hypertension, progressive loss of renal function, along 
with high incidence of cardiovascular morbidity and 
mortality. The four most important risk aspects and 
markers for these consequences are hyperglycemia, 
hypertension, hyperlipidemia and proteinuria(De 
Zeeuw et al., 2004). Diabetic nephropathy is a clinical 
syndrome characterized by persistent albuminuria, a 
constant decline glomerular filtration rate (GFR), 
elevated arterial blood pressure and increased relative 
mortality of cardiovascular patients. This follows with 
a more rapid progression of other secondary 
complications, (retinopathy, diabetic foot, neuropathy 
and hypertension (El-Menyar et al., 2016). 
Microvascular complications such as Retinopathy, 
nephropathy and neuropathy are chronic 
complications responsible for high morbidity and 
mortality in type 1 diabetes (Lipner et al., 2015). 
 
Diabetes nephropathy ultimately occurs with lesions 
that developed before many years. The usual history 
of nephropathy in insulin dependent diabetes mellitus 
(IDDM) is describe by a extended duration of medical 
stillness during delicate defects occur including 
increased GFR and resting microalbuminuria or 
exercise-induced along with an amplified kidney size 
(da Rocha Fernandes et al., 2016). Diabetic 
nephropathy usually develops in 30-50% with history 
of 15 to 25 years of diabetes mellitus (Sandholm et al., 
2017). Diabetic nephropathy is one of an etiological 
factor of end stage renal disease (ESRD) in the United 
State with prevalence of 158 per million. Diabetic 
patients are more susceptible to chronic kidney disease 
(Van Buren and Toto, 2011).  
 
Limited data are available about nephropathy 
incidence in diabetes mellitus type I in our population. 
Moreover, it is important to known that burden of 
diabetes across different regions of the world. 
Additionally, this study will help us in future to 
identify new prevention opportunities. Therefore, 
current study was design to evaluate the burden of 
diabetes and incidence of diabetic nephropathy in 
Type I and Type II diabetes patients in Peshawar. 
 
MATERIALS AND METHODS: 
Study site and design: 
This cross-sectional study was conducted on confirm 
diabetic patients in district Peshawar in period of one 
year (January 2018-February 2019).  
 
Study Population: 
Known diabetic patients visiting to hospital for their 
routine checkup were signed for this study after taking 
informed consent from patient/guardian in mentioned 
duration. 
All those patients who are not diabetic and those not 
willing to be the part of this study were excluded from 
current study. Data and samples were collected from 
outdoor patients and samples were processed in 
pathology department of Hayatabad Medical 
Complex, Peshawar. 
 
Sample size: 
Total of 267 blood samples of Diabetic patients 
were collected.  
 
Sample collection and Procedure: 
About 5 mL of venous blood was collected aseptically 
in vacutainer tube using venipuncture technique. 
Serum was stored after proper centrifugation. Along 
with blood sample, urine samples of the same patients 
were also collected in a sterilize containers. To study 
the diabetic nephropathy, the three most clinically 
important parameters were checked (serum creatinine, 
urea and urine albumin) using commercially available 
biochemistry kits of Randox Company and processed 
on Spectrophotometer (Microlab 200), while urine 
sample was checked for the presence of albumin by 
dip stick method. 
 
Statistical analysis: 
Data collected from above mentioned assays was 
analyzed by using ratios and percentages calculated 
for different variables and were analyzed by statistical 
package for social sciences (SPSS) version 21. 
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RESULTS: 
A total of 267 known diabetic patients were followed 
during study period. Out of 267 known diabetic 
patients, 82(30.7%) were male and 185 (69.3%) were 
female.Out of total, 43 (16.1%) was Type I diabetic 
patients whereas 224 (83.9%) were Type II diabetic 
patients as shown in figure No.1. 
 
 
Figure No.1:Distribution of diabetic patients according to gender and types of diabetes 
 
After follow up 267 known diabetic patients, 33 (12.4%) patients have high level of serum creatinine and urea along 
with the high concentration of albumin amount in urine were consider as nephropathic patients in this study as shown 
in figure No.2. 
 
 
Figure No.2:Burden of Nephropathic patients in diabetic mellitus patients 
 
Out of 33 nephropathic patients, 11 (32.3%) were Type I diabetic nephropathy patients whereas 22 (66.7%) were Type 
II diabetic nephropathy as show in figure No.3. 
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Figure No.3:Nephropathic patients were distributed according to the type of diabetes 
 
In total nephropathic patients (n=33), 14 (42.4%) were male while 19 (57.6%) were femalein current study as shown 
in Table No.1.  
 
 
 
Table No.1:Distribution of Nephropathic patients according to gender wise. 
Total Diabetic Nephropathic 
Patients 
Male Diabetic Nephropathic 
Patients 
Female Diabetic Nephropathic 
Patients 
33 14 (42.4%) 19 (57.6%) 
 
 
DISCUSSION: 
This current study determined the burden of diabetic 
mellitus type I and type II along with the observation 
of incidence of the nephropathy (kidney diseases) in 
both male and female diabetic patients. Different 
studies reported from various countries with variable 
burden and incidence of nephropathy. 
 
Present study result shows that frequency of diabetes 
type II (83.9%) are more as compared to the diabetes 
type I (16.1%). Rehman et.al (2004) reported from 
Peshawar that 35.6% frequency of diabetes type 
I(Rehman et al., 2005), which is 2 times greater than 
current study. This variation could be due to 
differentiation of sample size, kits and method of 
identification. 
 
High percentage of diabetic patients (type I and II) was 
female (69.3%) after comparing with male population 
(30.7%) in our study. Rehman et.al (2004) reported 
from Peshawar that percentage of diabetic male 
(58.9%) are high as compared to female level 
(42.1%)(Rehman et al., 2005). This could be due to 
high population of male in his study. Female are prone 
to diabetes as compared to male was revealed by other 
studies like present study (Li et al., 2016). 
The results of this follow up study revealed that the 
incidence of nephropathy is 12.4% in diabetic patients. 
In addition to above mentioned findings, 66.7% 
nephropathy was observed in diabetes mellitus type I 
patients while diabetes mellitus type II was in 33.3%, 
it could be due to high prevalence of diabetes mellitus 
type I. Study revealed from Oman that incidence of 
nephropathy is 42.5% (Alrawahi et al., 2012), which 
is high as compared to present report. It might be due 
to differentiation in diagnostic tools and ethinicity. 
Enlarge scale study conducted by Wu AY et.al in 
Asian which revealed variation in results of different 
countries (14.2% in Iran, 24.2% in Pakistan, 36.3% in 
India and 56.5% in Korea) (Wu et al., 2005). 
 
High percentage of nephropathy was found in female 
diabetic patients in a current study. Greater risk to 
female also reported by different researchers from 
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other regions of the world (Alrawahi et al., 2012, 
Soriguer et al., 2012)which could be due to weak 
glycemic and systolic blood pressure control in female 
(Goñi et al., 2016). The risks of nephropathy between 
sexes influence by different factors such as hormones, 
genetic and environmental factors (Hovind et al., 
2004).  
 
The main strength of present study is that many 
patients were followed in several intervals of study 
duration. Another positive feature is that gender was 
also studied. Moreover, this study also determined the 
current situation of the both diabetes mellitus type I 
and type II along with nephropathy. Despite the 
strength of this study, some limitations are also 
noteworthy. Less sample size, insufficient duration of 
study for prospective study, no clinical history was 
observed and risk factors were also not studied. 
Further studies are required to evaluate diabetes in 
pediatric age along with genetic diseases, clinical and 
family history of patients. Need unusual attention to 
risk factors responsible for high nephropathy in female 
diabetes after these findings of current study. 
Moreover, implementation of better and more 
successful management strategies for patients with 
diabetes is important. 
 
CONCLUSION: 
This study provides the up-to-dated information 
regarding the burden of diabetes, its types and 
incidence of nephropathy in diabetic patients. The 
prevalence of diabetes mellitus was observed while the 
nephropathy incidence was 12.4% in diabetic patients. 
Nephropathy incidence is quiet lower than other 
reported studies. Despite of less burden still need 
future management regarding prevention and 
treatment of diabetes and nephropathy in diabetes 
especially in females. 
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